2026

Project launch
in Almaty

Manufacturing Liquid and Solid Dosage Forms

Launching Kazakhstan’s
First Class A Pharmaceutical Plant

Pharmaceutical Manufacturing. GMP

53%

Financial Model

Projected EBITA Margin

Planned Facility Area

25,000 m²

25

70

6 Core Therapeutic Areas

Brands in the Portfolio

$ 95 miln

Private Capital

Planned Investment

Manufacturing, laboratories, warehousing and utilities integrated into a single GMP environment

Where Technology Becomes Affordable Medicine

Abdullah Turkoglu

Chief Executive Officer
Novem Pharmaceuticals LLP

We believe that good health is the foundation of a happy, successful and fulfilling life. It enables people to live fully, create, care for their loved ones and contribute to the well-being of society.

We are building the pharmaceutical manufacturing of tomorrow to support the health of future generations in Kazakhstan, a young and ambitious country with a rich history and strong traditions.

We have a clear understanding of our goals and our responsibility to people, society and our country. Our mission is to establish a modern pharmaceutical manufacturing facility where advanced technology, high quality standards and professional expertise serve our central purpose: human health and well-being.

Yours sincerely,

Dear Friends,

Building a Future for a Healthy Generation

Message from the CEO

Vision and Mission

To work with global healthcare leaders and make a meaningful contribution to both our industry and society.

To advance our own research, keep our facilities and product portfolio up to date, expand our market presence and enter international markets.

To become a successful pharmaceutical company meeting the needs of people across Central Asia with high-quality products.

To embrace continuous learning and improvement, achieving sustainable growth in a changing and competitive environment.

Vision

To build relationships based on trust and respect with customers, business partners and society.

To act responsibly and contribute to the country’s sustainable development.

To contribute to the development of Kazakhstan’s pharmaceutical market by providing affordable, effective and high-quality medicines.

To unite our departments as one team committed to continuous professional development.

Mission

Our Guiding Principles

Full-Cycle Manufacturing.
Quality at Every Stage.

From incoming inspection of active pharmaceutical ingredients to finished dosage forms, warehousing and delivery to customers.

GMP Manufacturing Environment

Developing or adapting drug formulations and manufacturing processes to the production site. Preparing documentation, manufacturing pilot batches and verifying stability.

Critical quality parameters are monitored at every stage of manufacturing. Each subsequent operation begins only after compliance with the specified requirements has been confirmed.

Design and construction in line with GMP requirements, with future MHRA certification in view

International Standards

Multi-stage control of raw materials, processes and finished products throughout manufacturing

In-House Laboratory

Advanced Equipment

Production lines from leading global manufacturers, selected with future expansion in mind

Technology, Quality and International Standards
in One Integrated System

Medicines for gastrointestinal disorders.

Gastroenterology

Medicines for neurological and psychiatric disorders.

Neurology and Psychiatry

Oncology

Medicines for modern cancer treatment.

Pain Management

Non-steroidal anti-inflammatory drugs (NSAIDs).

Medicines for long-term, ongoing treatment.

Hormone Therapy

Medicines for cardiovascular diseases.

Cardiology

Our portfolio is being developed with Kazakhstan’s healthcare needs, reliance on imports and local manufacturing capabilities in mind.

Planned Dosage Forms:

Medicines to Meet Healthcare Needs

Suppositories

Gels

Powders and Solutions for Injection

Lyophilised Products

ODT

Capsules

Tablets

Expanding the product portfolio and manufacturing capacity. Entering export markets and additional markets.

2032+

Expansion

5

Starting commercial-scale pharmaceutical production and entering the public procurement and private markets. Securing ongoing contracts and stable supply volumes.

Production Launch

2029 - 2030

4

Equipment qualification, validation of processes and premises, and preparation for GMP certification. Registration of medicinal products.

June 2028 – January 2029

Certification and Registration

3

Preparing the site within the Special Economic Zone, constructing manufacturing and warehousing facilities, and connecting utility and engineering networks.

April 2027 – May 2028

Construction and Infrastructure

2

Finalising the plant concept, designing the facility to meet GMP requirements and preparing documentation for permits and approvals.

Design and Preparation

2026 - March 2027

1

Project Timeline

The project follows a phased approach, from concept development and plant construction to the start of manufacturing and entry into international markets.

Export